Treatments like chemotherapy and radiation can be lifesaving when you have cancer. Unfortunately, these treatments can potentially damage your heart. At the Allegheny Health Network (AHN) Cardiovascular Institute, our heart specialists partner with your oncologist to protect your heart while you undergo cancer treatments.
Certain cancer treatments, such as chemotherapy, radiation, and immunotherapies, can be toxic to your heart. This treatment side effect is called cardiotoxicity.
Your heart may weaken (heart failure) or beat out of rhythm (a condition known as arrhythmia). You also may experience high blood pressure, or hypertension, a condition that increases your risk of stroke and heart attack. You may continue to be at risk for these problems even after you’re finished with cancer treatments.
Our goal is to prevent and minimize heart damage while you continue the best treatment for cancer. Cardiologists at the Cardio-Oncology Clinic manage patients before, during, or after cancer therapy, including:
At AHN, you benefit from:
Our heart specialists coordinate care with experts from the AHN Cancer Institute. Together, we develop a treatment plan to ensure that you receive the optimum benefits from your cardiotoxicity treatment, while also preventing heart problems. As new cancer treatments come about, our cardio-oncologists evaluate and manage the cardiovascular risks that may come along.
We offer advanced diagnostic services and testing to detect early signs of cardiotoxicity as well as treatment that is specific to the patient. You may receive care at the AHN Cardio-Oncology Clinic at Allegheny General Hospital, Saint Vincent Hospital, or Wexford Health + Wellness Pavilion.
We use the latest technology to detect early signs of heart problems, including:
This test helps predict heart damage by checking for shortening, lengthening, or thickening of heart muscle. Our physicians perform baseline echos at the start of cancer treatments and compare results to follow-up tests to quickly detect problems.
This test uses a specialized camera and an injectable radioactive tracer to evaluate your heart’s pumping action.
This noninvasive test relies on radiofrequency waves and magnets to create detailed 3D still images and real-time videos of your heart and circulatory system. Learn more about cardiovascular imaging.
Blood tests taken throughout your cardiotoxicity treatment help identify damaged cells called biomarkers that may indicate heart damage.
At the AHN Cardiovascular Institute, you have access to a wide range of heart-saving cardiotoxicity treatments. To prevent or stop cardiotoxicity, your physician may recommend:
Call (412) DOCTORS (412) 362-8677 or request an appointment with AHN cardiovascular services.